Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07804849
Recruiting
Oral Verapamil Among Newly Diagnosed Children and Adolescents With Type 1 Diabetes
Phase 2/3 · Egypt · 1 site
Registry update: 4 Sept 2026
NCT07662824
Recruiting
Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy
Not applicable · United States · 1 site
Registry update: 31 Aug 2026
NCT07741981
Recruiting
Treatment Resistance in Psychiatric Disorders: the Search for Biological Markers Predictive of Response to Treatment
Not applicable · France · 1 site
Registry update: 21 Sept 2026
NCT07784374
Recruiting
A Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D Mutation
Phase 2 · China · 1 site
Registry update: 2 Oct 2026
NCT07790809
Recruiting
Safety and Short-term Outcomes of Modular Robotic System for Siewert II/III Gastroesophageal Junction Cancer
Not applicable · China · 1 site
Registry update: 2 Sept 2026
NCT07784270
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Phase 3 · Argentina, Australia, Canada, Chile, China, Germany, Spain, United Kingdom, Hungary, India, Japan, South Korea, Poland, Slovakia, Taiwan, United States · 190 sites
Registry update: 28 Oct 2026
NCT07772921
Recruiting
A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma
Phase 3 · Japan, United States · 16 sites
Registry update: 30 Oct 2026
NCT07686263
Recruiting
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Phase 3 · Argentina, Bulgaria, Czechia, Denmark, Spain, Poland, Romania, United States · 52 sites
Registry update: 30 Oct 2026
NCT07514819
Recruiting
Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Not applicable · United States · 1 site
Registry update: 21 Aug 2026
NCT07801235
Recruiting
HYperfractionated Radiation Therapy Versus Concurrent Chemoradiation for Head and Neck Cancer (HYTC)
Not applicable · Jordan · 1 site
Registry update: 14 Oct 2026
NCT06622174
Recruiting
Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer
Phase 1 · Canada · 1 site
Registry update: 24 Aug 2026
NCT06716021
Recruiting
ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3
Phase 3 · Canada, Spain, Netherlands, United States · 34 sites
Registry update: 7 Oct 2026
NCT07275905
Recruiting
Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection
Phase 1 · United States · 1 site
Registry update: 8 Oct 2026
NCT07780500
Recruiting
REFOCUS-HTN US-WEST: A Data Infrastructure to Characterize Individuals With Hypertension
Not applicable · United States · 1 site
Registry update: 5 Oct 2026
NCT07726784
Recruiting
Safety and Feasibility of Medical Thoracoscopy Using Single-use Flexible Bronchoscope Versus SemiRigid Pleuroscope in Pleural Effusion
Not applicable · Malaysia · 2 sites
Registry update: 11 Sept 2026
2022-502365-26-00
Recruiting
A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.
Phase 3 · Germany, Spain, France, Hungary, Poland, Romania, Slovakia · 34 sites
Registry update: 4 Aug 2026
NCT07508995
Recruiting
A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)
Phase 2 · United States · 1 site
Registry update: 29 Oct 2026
NCT07460986
Recruiting
A Phase Ib/II Study to Evaluate Safety and Efficacy of Bexmarilimab in Combination With Doxorubicin in Metastatic Soft-tissue Sarcoma.
Phase 1/2 · Spain · 12 sites
Registry update: 31 Aug 2026
NCT07786766
Recruiting
Pemigatinib Plus PD-1 Inhibitor With or Without Chemotherapy in FGFR2 Fusion/Rearrangement-Positive Cholangiocarcinoma
Phase 2 · China · 1 site
Registry update: 26 Aug 2026
NCT07579195
Recruiting
Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
Phase 1/2 · United States · 1 site
Registry update: 25 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.